Thymosin alpha-1
Also known as: Thymalfasin, Zadaxin, Tα1, Ta1
Classification
Peptide
Regulatory Status
not-established
Sources
10
Review
n/a
Overview
Thymosin alpha-1 (thymalfasin) is a synthetic 28-amino-acid acetylated thymic peptide described as modulating innate and adaptive immune signaling, including TLR-related dendritic-cell pathways and T-cell maturation.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
immune cells / TLR-associated pathways (described)
Interactions & cautions
Drug interactions
immunosuppressants or post-transplant regimens — May theoretically counteract immunosuppression or aggravate GVHD risk flagged in FDA materials (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw